Graft Polymer CTO Bolduev Steps Down Amid Strategic Shift
Company Announcements

Graft Polymer CTO Bolduev Steps Down Amid Strategic Shift

Graft Polymer (UK) PLC (GB:GPL) has released an update.

Graft Polymer (UK) PLC, a leader in biopolymer drug delivery systems, has announced the immediate resignation of Mr. Victor Bolduev, its CTO and board member. This follows a strategic shift to focus on healthcare opportunities and a collaboration with Awakn Life Sciences Corp, marked by the recent appointment of Professor David Nutt as Senior Scientific Adviser. The move aligns with the company’s divestiture of its industrial plastics division earlier this year.

For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskGraft Polymer Advances PTSD Therapeutic Research
TipRanks UK Auto-Generated NewsdeskGraft Polymer Advances PTSD Treatment Research
TipRanks UK Auto-Generated NewsdeskGraft Polymer Welcomes New Chairman
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App